Stocks rise as yields slip; Moderna drives healthcare gains
Moderna’s surge offset broader caution as investors parsed mixed earnings signals and shifting rate expectations.
U.S. equities advanced as Treasury yields pulled back. Healthcare led gains after Moderna’s late-session rally.
Yields pull back, lifting equities
U.S. stocks climbed Wednesday as benchmark Treasury yields eased from recent highs. The 10-year yield dipped below 4.2%, reducing pressure on rate-sensitive sectors. The S&P 500 and Dow Jones Industrial Average both finished higher, while the Nasdaq lagged slightly on tech’s uneven tone.
Healthcare catches a bid on Moderna strength
Moderna surged nearly 12% after reporting positive late-stage data for its mRNA-based RSV vaccine. The move lifted the broader healthcare sector, which outperformed the broader market. Traders rotated into biotech names, though some warned of potential profit-taking after the sharp rally.
Mixed breadth signals caution beneath the surface
Internal breadth metrics for tracked stock setups showed a mixed backdrop, with average confidence near 67%. While leadership was concentrated in healthcare, other sectors like financials and energy lagged. This divergence raises questions about the durability of the rally without broader participation.
What traders should watch next
The key risk now is whether the yield pullback holds or reverses. A rebound in yields could pressure growth stocks, while a sustained decline may extend the healthcare rally. Traders will also monitor upcoming economic data and earnings for signs of whether this move has legs beyond the immediate momentum.